Abstract: The present disclosure provides a composition comprising 10-hydroxydecanoic acid and at least one small molecule, N-{2-[4-(methylsulfanyl)phenyl]ethyl}-1-propanoyl-2,3-dihydro-1H-indole-2-Carboxamide, or N-[2-(4-ethylpiperazin-1-yl)ethyl]-1-propanoyl-2,3-dihydroindole-2-carboxamide or combinations thereof, which is useful in inhibiting skin aging. Formulations, and methods of inhibiting skin aging and also provided in the instant disclosure.
Claims:1. A composition for cosmetic inhibition of skin aging, said composition comprising:
- 10-hydroxydecanoic acid; and
- at least one compound selected from the group consisting of N-{2-[4-(methylsulfanyl)phenyl]ethyl}-1-propanoyl-2,3-dihydro-1H-indole-2-carboxamide, N-[2-(4-ethylpiperazin-1-yl)ethyl]-1-propanoyl-2,3-dihydroindole-2-carboxamide, and
combination thereof,
wherein 10-hydroxydecanoic acid to at least one compound w/w ratio in said composition is in the range of 1:0.01-1:0.2.
2. The composition as claimed in claim 1, wherein 10-hydroxydecanoic acid to at least one compound w/w ratio in said composition is in the range of 1:0.025-1:0.1.
3. The composition as claimed in any of the claims 1-2,wherein 10 -hydroxydecanoic acid to N-{2-[4-(methylsulfanyl)phenyl]ethyl}-1-propanoyl-2,3-dihydro-1H-indole-2-carboxamide; or 10 hydroxydecanoic acid to N-[2-(4-ethylpiperazin-1-yl)ethyl]-1-propanoyl-2,3-dihydroindole-2-carboxamide w/w ratio in said composition is 1:0.1.
4. A method of preparing a composition as claimed in any of the claims 1-3.
5. A formulation for cosmetic inhibition of skin aging, said formulation comprising:
- 10-hydroxydecanoic acid;
- at least one compound selected from the group consisting of N-{2-[4-(methylsulfanyl)phenyl]ethyl}-1-propanoyl-2,3-dihydro-1H-indole-2-carboxamide, N-[2-(4-ethylpiperazin-1-yl)ethyl]-1-propanoyl-2,3-dihydroindole-2-carboxamide, and
combinations thereof; and
- suitable carriers, diluents, and excipients,
wherein 10-hydroxydecanoic acid to at least one compound w/w ratio in said composition is in the range of 1:0.01-1:0.2.
6. The formulation as claimed in claim 5, wherein 10-hydroxydecanoic acid to at least one compound w/w ratio in said formulation is in the range of 1:0.025-1:0.1.
7. The formulation as claimed in any of the claims 5-6, wherein 10 -hydroxydecanoic acid to N-{2-[4-(methylsulfanyl)phenyl]ethyl}-1-propanoyl-2,3-dihydro-1H-indole-2-carboxamide; or 10 hydroxydecanoic acid to N-[2-(4-ethylpiperazin-1-yl)ethyl]-1-propanoyl-2,3-dihydroindole-2-carboxamide w/w ratio in said formulation is 1:0.1.
8. A method of preparing a formulation as claimed in any of the claims 5-7.
9. A method of cosmetic inhibition of skin aging, said method comprising:
- obtaining a composition as claimed in any of the claims 1-3; or a formulation as claimed in any of the claims 5-7; and
- contacting said composition or formulation with skin,
wherein said method cosmetically inhibits skin aging.
10. A composition as claimed in any of the claims 1-3; or a formulation as claimed in any of the claims 5-7 for use in topical application for cosmetic inhibition of skin aging.
, Description:
| # | Name | Date |
|---|---|---|
| 1 | 6162-CHE-2015-FER.pdf | 2020-04-28 |
| 1 | Form 5 [16-11-2015(online)].pdf | 2015-11-16 |
| 2 | 6162-CHE-2015-FORM 18 [29-09-2019(online)].pdf | 2019-09-29 |
| 2 | Form 3 [16-11-2015(online)].pdf | 2015-11-16 |
| 3 | 6162-CHE-2015-Correspondence-F1-PA-281215.pdf | 2016-06-15 |
| 3 | Drawing [16-11-2015(online)].pdf | 2015-11-16 |
| 4 | 6162-CHE-2015-Form 1-281215.pdf | 2016-06-15 |
| 4 | Description(Complete) [16-11-2015(online)].pdf | 2015-11-16 |
| 5 | 6162-CHE-2015-Power of Attorney-281215.pdf | 2016-06-15 |
| 6 | 6162-CHE-2015-Form 1-281215.pdf | 2016-06-15 |
| 6 | Description(Complete) [16-11-2015(online)].pdf | 2015-11-16 |
| 7 | 6162-CHE-2015-Correspondence-F1-PA-281215.pdf | 2016-06-15 |
| 7 | Drawing [16-11-2015(online)].pdf | 2015-11-16 |
| 8 | 6162-CHE-2015-FORM 18 [29-09-2019(online)].pdf | 2019-09-29 |
| 8 | Form 3 [16-11-2015(online)].pdf | 2015-11-16 |
| 9 | 6162-CHE-2015-FER.pdf | 2020-04-28 |
| 9 | Form 5 [16-11-2015(online)].pdf | 2015-11-16 |
| 1 | 2020-03-1210-35-43E_12-03-2020.pdf |